Healthy Skepticism Library item: 5682
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: news
Re: the promotion of Toradol (ketorolac)
1993 Jun
Abstract:
In Australia Syntex’s promotion for Toradol (ketorolac) does not mention the adverse effects associated with the product and claims that it is as effective as narcotic analgesics.
Keywords:
*analysis/Australia/developed countries/Syntex/ketorolac/Toradol/NSAID/safety & risk information/ nonsteroidal anti-inflammatory drugs/quality of information/MaLAM/Medical Lobby for Appropriate Marketing/analgesics/EVALUATION OF PROMOTION: DRUG SAFETY/EVALUATION OF PROMOTION: PROMOTIONAL BROCHURES/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES